Evidence map›Paper›PMID 20545707›Full record

ReviewClinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology2010

Pro/Con debate: Is occupational asthma induced by isocyanates an immunoglobulin E-mediated disease?

A V Wisnewski, M Jones

Open access · greenAbstract readReview
In one paragraph

Review in Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.9field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 46 citations in OpenAlex.

  1. New mechanisms in diisocyanate-mediated allergy/toxicity: are microRNAs in play?Current opinion in allergy and clinical immunology · 2025
    Review
  2. Article
  3. Article
  4. Article
  5. Analysis of Lung Gene Expression Reveals a Role for ClAmerican journal of respiratory cell and molecular biology · 2020
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Usefulness of Biomarkers in Work-Related Airway Disease.Current treatment options in allergy · 2017
    Review
  12. Article
  13. Review
  14. Occupational asthma in a cable manufacturing company.Iranian Red Crescent medical journal · 2014
    Article
  15. Article
  16. Article
  17. Article
  18. Hexamethylene diisocyanate (HDI) vapor reactivity with glutathione and subsequent transfer to human albumin.Toxicology in vitro : an international journal published in association with BIBRA · 2013
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

A V WisnewskiDepartment of Medicine, Yale University School of Medicine, New Haven, CT 06520-8057, USA. adam.wisnewski@yale.edu
M Jones
Imperial College London · GBYale University · US

Funding

New Serodiagnostics for Isocyanate Exposure, A Major Cause of Occupational AsthmaR42ES016728 · NIEHS · L2 DIAGNOSTICS, LLC · PI WISNEWSKI, ADAM · 2009 to 2010
$710k
New Serodiagnostics for Isocyanate Exposure, A Major Cause of Occupational AsthmaR41ES016728 · NIEHS · L2 DIAGNOSTICS, LLC · PI WISNEWSKI, ADAM · 2008 to 2008
$203k
NIEHS NIH HHS R41 ES016728NIEHS NIH HHS R42 ES016728
6 · The paper itself

Abstract

Isocyanates, low-molecular weight chemicals essential to polyurethane production, are one of the most common causes of occupational asthma, yet the mechanisms by which exposure leads to disease remain unclear. While isocyanate asthma closely mirrors other Type I Immune Hypersensitivity (Allergic) disorders, one important characteristic of hypersensitivity ('allergen'-specific IgE) is reportedly absent in a large portion of affected individuals. This variation from common environmental asthma (which typically is induced by high-molecular weight allergens) is important for two reasons. (1) Allergen-specific IgE is an important mediator of many of the symptoms of bronchial hyper-reactivity in 'allergic asthma'. Lack of allergen-specific IgE in isocyanate hypersensitive individuals suggests differences in pathogenic mechanisms, with potentially unique targets for prevention and therapy. (2) Allergen-specific IgE forms the basis of the most commonly used diagnostic tests for hypersensitivity (skin prick and RAST). Without allergen-specific IgE, isocyanates may go unrecognized as the cause of asthma. In hypersensitive individuals, chronic exposure can lead to bronchial hyperreactivity that persists years after exposure ceases. Thus, the question of whether or not isocyanate asthma is an IgE-mediated disease, has important implications for disease screening/surveillance, diagnosis, treatment and prevention. The present Pro/Con Debate, addresses contemporary, controversial issues regarding IgE in isocyanate asthma.

Indexed as

AsthmaHumansImmunoglobulin EIsocyanatesOccupational DiseasesImmunoglobulin EIsocyanates

Identifiers

PMID20545707
PMCPMC3121887
OpenAlexW1499931768

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.